On the whole, our studies did substantiate the disease significance (though minor) of variants in Kir4.1 in ASD and comorbid epilepsy and offered new possible molecular therapeutic targets in neurodevelopmental disorders. This evidence concerns the gene KCNJ10 and neurodevelopmental disorder.